GMI-1271

GMI-1271 · GlycoMimetics Incorporated

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GMI-1271, covering 2018-02-27 to 2019-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML [Phase 1, Phase 2]

See pricing